Trial Profile
Effect of imatinib in patients with Chronic Myeloid Leukemia who achieved Early Molecular Response at 3, 6 or 12 months
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 May 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 21 May 2015 New trial record